Xofigo Radium-223 in Israel — get 3 top clinic matches with costs

Xofigo Radium-223 side effects include nausea, diarrhea, and fatigue, as the alpha-particle medication targets bone metastases. Common hematological responses include temporary drops in red blood cell counts. Israeli oncology centers like Sourasky Medical Center manage these effects through specialized intravenous infusion protocols and supportive care.

• Gastrointestinal response: Nausea and loss of appetite typically occur during the first week after injection.
• Hematological monitoring: Blood work may show temporary red blood cell fluctuations a few weeks post-treatment.
• Physical energy: Fatigue is frequently reported in the immediate period following the intravenous infusion.
• Oral health: Dry mouth (Xerostomia) is a principal adverse effect and can sometimes become irreversible.

Bookimed Expert Insight: While Xofigo primarily causes fatigue, many patients accidentally confuse its side effects with thyroid-related radioactive iodine therapy. Top Israeli specialists like Dr. Ofer Merimsky emphasize aggressive hydration specifically to mitigate oral side effects, a detail often overlooked in standard oncology consultations.

Patient Consensus: Many patients emphasize the need for regular blood monitoring to track cell counts. People frequently recommend aggressive hydration to manage dry mouth symptoms effectively after each injection.

Xofigo causes bone marrow suppression because the radioactive Radium-223 isotope mimics calcium, targeting bone metastases near blood-cell-producing tissue. While most patients experience temporary drops in red blood cells or platelets, 2% may face serious bone marrow failure requiring close hematologic monitoring.

• Affected cells: Treatment lowers counts of red cells, white cells, and platelets.
• Monitoring protocol: Israeli oncology centers perform blood tests before each of the 6 injections.
• Recovery timeline: Blood cell levels typically recover naturally within several weeks post-treatment.
• Severe risks: Clinical data shows a 2% risk of fatal bone marrow failure.

Bookimed Expert Insight: Israeli centers like Sourasky manage these risks by leveraging EBMT-certified hematology standards. While Xofigo costs $24,000 to $32,000 here, the true value lies in specialized monitoring. Professor Ofer Merimsky at Sourasky coordinates care to identify count drops early, maintaining a safer profile compared to standard radiotherapy.

Patient Consensus: Most patients report mild fatigue and occasional bruising but find the blood count drops are temporary. Many emphasize that this hematologic impact resolves much easier than the permanent side effects of other radiation therapies.

Radiation safety protocols for Xofigo Radium-223 focus on managing internal alpha-emitter isotopes. Patients must minimize contact with biological waste for several days following injection. While alpha radiation travels short distances, strict hygiene prevents accidental ingestion by family members within JCI-accredited facilities in Israel.

• Hygiene protocol: Flush toilets twice after use to clear biological waste safely.
• Personal contact: Limit close contact with children and pregnant women for 3–7 days.
• Waste management: Wash hands thoroughly after urination to prevent internalizing radioactive materials.
• Sleeping arrangements: Use a separate bed for 3–5 nights to minimize proximity.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center manage 40,000 cancer patients yearly with high efficiency. For Xofigo therapy, the cost ranges from $24,000 to $32,000, which is a significant saving of 69% compared to the US average of $90,000. These savings often cover extra nights in local accommodations, which simplifies following the 5-day isolation period before traveling home.

Patient Consensus: Accuracy in hygiene is vital since radiation risks are internal rather than external. Patients recommend requesting a specific safety brochure from your oncologist to navigate home-care protocols confidently.

Xofigo (Radium-223) is a targeted radioactive treatment for men with castration-resistant prostate cancer that has spread to the bones. This alpha-emitting radiopharmaceutical mimics calcium to target bone metastases, delivering localized radiation that destroys cancer cells while sparing surrounding healthy tissue and critical organs.

• Targeted indication: Used for symptomatic bone metastases without known visceral spread to organs.
• Treatment mechanism: Acts as a calcium analog to deliver short-range alpha radiation to tumors.
• Standard protocol: Administered via intravenous infusion every 4 weeks for 6 total sessions.
• Clinical benefits: Designed to extend survival and significantly reduce cancer-related bone pain.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center (Ichilov) serve 40,000 cancer patients annually. This volume is critical because Xofigo requires precise nuclear medicine handling. If cancer spreads beyond the bones, Israeli specialists often pivot to Lutetium-177 (Pluvicto) as a more effective systemic alternative.

Patient Consensus: Patients emphasize that Xofigo is most effective when bone pain is the primary symptom. While some see immediate relief, others suggest discussing Lutetium-177 if imaging shows the disease moving into the liver or lungs.

Candidates for Xofigo in Israel include adult men with metastatic castration-resistant prostate cancer experiencing symptomatic bone metastases. These patients typically exhibit disease progression despite hormonal therapy and have no known visceral metastases in the lungs or liver, confirmed via PSMA PET/CT scans at centers like Sourasky.

• Cancer stage: Confirmed castration-resistant prostate cancer showing progression despite therapy.
• Metastatic status: Documented symptomatic spread specifically to the bone structure.
• Exclusion criteria: Absence of significant visceral involvement in internal organs.
• Facility standard: Joint Commission International accredited hospitals managing 40,000+ oncology patients.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center offer Xofigo at $24,000 to $32,000, which is 69% less than the $90,000 American average. This cost difference allows patients to access advanced diagnostics like Novalis TrueBeam STx and Foundation One CDx testing within the same therapeutic budget.

Patient Consensus: Patients emphasize verifying bone-only status through imaging before arrival to ensure eligibility. Most describe the outpatient infusion as manageable with significantly fewer side effects than traditional chemotherapy regimens.

Xofigo can be combined with hormone therapies like LHRH analogues and enzalutamide to treat prostate cancer. However, it must not be used with abiraterone acetate or chemotherapy. These combinations significantly increase the risk of fractures, bone marrow suppression, and mortality.

• Safe combinations: Clinics use Xofigo alongside hormone therapies like LHRH analogues or enzalutamide safely.
• High-risk pairings: Doctors strictly avoid abiraterone (Zytiga) to prevent fatal bone fractures and death.
• Sequential therapy: Specialists like Dr. Ofer Merimsky may sequence Xofigo with Lutetium-177 radioligand therapy.
• Local integration: Stereotactic body radiation therapy (SBRT) often manages specific painful lesions during systemic treatment.

Bookimed Expert Insight: While global guidelines allow enzalutamide, Israeli oncologists at Sourasky Medical Center prioritize marrow health. They often reserve Xofigo as a third-line therapy. This strategy preserves bone marrow function for secondary treatments like Lutetium-177. Patients with existing marrow issues may be ineligible for combining these powerful radiopharmaceuticals.

Patient Consensus: Patients emphasize verifying bone marrow status before starting. Many view Xofigo primarily as a tool for managing bone pain and improving daily quality of life.

Xofigo works by mimicking calcium to deliver targeted alpha-particle radiation directly to bone metastases. This therapy treats castration-resistant prostate cancer that has spread to bones. It destroys tumor DNA within a short range, preserving surrounding healthy tissue and bone marrow.

• Targeting mechanism: Radium-223 mimics calcium to seek out areas of high bone turnover.
• Radiation type: Alpha particles deliver high energy across just 10 cell diameters.
• Treatment cycle: Patients receive 6 intravenous injections spaced exactly 1 month apart.
• Pain management: Most patients report noticeable relief after their second or third injection.

Bookimed Expert Insight: While Xofigo targets bone lesions, Israeli oncology centers like Sourasky Medical Center often combine it with genetic testing like Foundation One CDx. This dual approach ensures the treatment matches the specific tumor profile. This is crucial because Xofigo only treats bone-specific spread, not soft-tissue metastases.

Patient Consensus: Patients should prepare for gradual improvements rather than instant results after the first dose. Common feedback highlights managing extreme fatigue and appetite changes during the 6-month course.

Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.

• Advanced technology: Clinics utilize MRI-guided focused ultrasound (MRgFUS) and robotic systems for incisions.
• Surgical expertise: Surgeons like Dr. Zvi Ram lead international associations with 25+ years experience.
• Rapid access: International patients typically schedule complex brain or spine surgeries within 2–4 weeks.
• Accredited care: Major centers like Sourasky (Ichilov) and Assuta hold JCI accreditation for safety.

Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.

Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.

Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.

• Oncological conditions: Treatment for gliomas, meningiomas, and pituitary tumors using skull base resection.
• Functional disorders: Management of Parkinson disease and essential tremors via deep brain stimulation.
• Spinal pathologies: Correction of scoliosis, herniated discs, and spinal tumors using robotic systems.
• Cerebrovascular care: Surgical repair of brain aneurysms and arteriovenous malformations with endovascular interventions.
• Pediatric neurosurgery: Specialized care for hydrocephalus and congenital anomalies at dedicated children centers.

Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.

Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.

Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.

• Sourasky (Ichilov): Performs 2,500+ neurosurgical operations yearly with a 98% success rate in Tel Aviv.
• Sheba Medical Center: Ranked among the world's top 10 hospitals. It treats 1.9 million patients annually.
• Hadassah Medical Center: A Nobel Peace Prize nominee. It leads in pediatric neurosurgery and gene-based therapies.
• Assuta Medical Center: Israel's largest private facility. It specializes in minimally invasive spine and brain surgeries.
• Schneider Children's: The primary center for pediatric neurosurgery. It treats 275,000 children every year.

Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.

Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.

Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.

• Prof. Zvi Ram: Expert in minimally invasive brain tumor surgery and gene-based oncology therapies.
• Prof. Shlomi Constantini: Specializes in complex pediatric neuro-endoscopy and brain tumor microsurgery.
• Prof. Itzhak Fried: Authority on epilepsy surgery, functional brain mapping, and deep brain stimulation.
• Dr. Eli Ashkenazi: Leading spine surgeon at Assuta, specializing in the innovative TOPS system.

Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.

Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.

International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.

• Medical documentation: Submit detailed English-translated reports and imaging for clinical review within 48 hours.
• Financial clearance: Provide proof of funds for approximately $24,000 to $32,000 for treatment.
• Visa support: Clinics like Sourasky Medical Center (Ichilov) issue official letters for medical B-2 visas.
• Consultation phase: Initial assessment often occurs via online consultation with surgeons like Dr. Strauss Ido.

Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.

Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.

A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.

• Hospitalization duration: Minimally invasive procedures require 1–3 days. Regular craniotomies average 3–10 days.
• Local recovery: Stay in Israel for 7–14 days post-discharge for mandatory follow-up checks.
• Flight safety: Surgeons recommend waiting 4–6 weeks before flying to stabilize internal head pressure.
• Follow-up schedule: In-person clinical reviews typically occur at days 3, 7, and 14 post-surgery.

Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.

Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.

Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.

• Robotic systems: Mazor and ROSA robotics enable precise instrument placement through tiny incisions.
• Incisionless ultrasound: MRgFUS uses high-intensity sound waves to treat brain tissue without anesthesia.
• Digital navigation: Intraoperative MRI and 3D mapping allow surgeons to verify results in real-time.
• Advanced endoscopy: Transnasal and trans-orbital approaches remove tumors without traditional skull-opening craniotomies.

Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.

Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.

Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.

• Advanced technology: Facilities use CyberKnife, Gamma Knife, and robotic systems for precision.
• Expert credentials: Specialists like Dr. Zvi Ram hold leadership roles in European neurosurgical societies.
• Global training: Most senior neurosurgeons completed fellowships at premier United States and European institutions.
• Specialized departments: Centers feature niche units for pediatric neurosurgery, skull base, and functional disorders.

Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.

Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.

Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.

• Sheba Medical Center: Ranked among the top 10 world hospitals by Newsweek magazine.
• Sourasky (Ichilov): Reports a 98% success rate and performs 2,500+ neurosurgical operations annually.
• Hadassah Medical Center: Known for pioneering endoscopic techniques and integrated advanced research programs.
• Assuta Medical Center: Israel largest private facility specializing in minimally invasive spine procedures.
• Rambam Medical Center: Employs Nobel Prize laureates and serves as a major referral center.

Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.

Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.

Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.

• Brain tumors: Professor Zvi Ram specializes in image-guided microsurgery and complex brain mapping techniques.
• Pediatric expertise: Professor Shlomi Constantini leads pediatric neurosurgery, focusing on endoscopic treatments and malformations.
• Functional surgery: Professor Itzhak Fried is a global authority on epilepsy and deep brain stimulation.
• Spine specialists: Dr. Zvi Lidar and Dr. Eli Ashkenazi focus on minimally invasive spinal oncology.

Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.

Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.

Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.

• Neuro-oncology: Treating glioblastoma, meningioma, and skull base tumors with 90% success rates.
• Functional neurosurgery: Performing deep brain stimulation (DBS) for Parkinson’s and drug-resistant epilepsy.
• Pediatric specialty: Specialized care for congenital defects and childhood tumors at Schneider Children’s.
• Spine surgery: Utilizing Mazor X robotic systems for scoliosis and herniated disc correction.

Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.

Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.

International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.

• Travel authorization: Most visa-exempt travelers now need an approved ETA-IL before departure.
• Hospital invitation: A signed letter from facilities like Sourasky Medical Center is required.
• Medical records: Provide updated summaries of diagnoses, medications, and previous neurological treatments.
• Imaging files: Digital copies of scans are essential for planning complex brain surgeries.
• Legal consent: Notarized power of attorney is required for patients under 18 years old.

Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.

Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.